Opioid Conversion Guidelines
Introduction to Opioid Conversion
- The Centers for Disease Control and Prevention (CDC) recommends converting fentanyl to morphine milligram equivalents (MME) using a conversion factor of 2.4 for fentanyl, applicable to total daily dose calculations, resulting in 1,200 MME/day for a patient on 500 mcg fentanyl daily 1, 4
- The CDC also recommends converting MME to oxycodone using a conversion factor of 1.5 for oxycodone, resulting in 800 mg oxycodone daily 1, 4
Conversion Calculation Process
- For a patient on 0.5mg (500 mcg) of fentanyl daily, the equivalent oxycodone dose is approximately 800 mg/day, but this should be reduced by 25-50% due to incomplete cross-tolerance, resulting in a starting dose of 400-600 mg oxycodone daily 1, 2, 3
- The National Comprehensive Cancer Network (NCCN) recommends reducing the calculated dose by 25-50% to account for incomplete cross-tolerance and individual pharmacokinetic variability, resulting in a starting dose of 400-600 mg oxycodone daily 2, 3
Critical Safety Considerations
- The CDC notes that doses above 90 MME/day are associated with progressively increased overdose risk, and 1,200 MME represents a potentially life-threatening dose for non-tolerant patients 1, 5
- The CDC recommends having naloxone immediately available and being prepared to provide respiratory support 5
Practical Dosing Algorithm
- The NCCN recommends starting with 400 mg oxycodone daily (50% dose reduction), divided into doses every 4-6 hours, and providing rescue doses of 10-20% of the 24-hour dose (40-80 mg) every 4-6 hours as needed for breakthrough pain 2, 3
- The NCCN also recommends reassessing pain control and adverse effects within 24-48 hours and titrating based on response 2, 6
Common Pitfalls to Avoid
- The CDC and NCCN recommend not using the calculated 800 mg dose directly without dose reduction, as this is a mathematical estimate only and does not account for incomplete cross-tolerance 1, 2, 3
- The CDC and NCCN also recommend accounting for the patient's renal and hepatic function, age, prior opioid exposure, and reason for switching (poor pain control vs. adverse effects) when converting opioids 2, 4